We are pleased to share that our work has been featured in the December 2025 issue of Nature Reviews Drug Discovery as part of the journal’s Research Highlights section.

The highlight discusses our research on targeting the extracellular matrix (ECM) in melanoma, an emerging area in cancer biology and drug discovery. The ECM is increasingly recognized as an active regulator of tumor progression, metastasis, and therapeutic response, rather than a passive structural component. Our work contributes to this growing field by demonstrating how modulation of ECM-related pathways can influence tumor behavior and reveal new therapeutic opportunities.

This recognition by Nature Reviews Drug Discovery underscores the relevance of ECM-focused approaches in understanding melanoma biology and advancing next-generation therapeutic strategies.

🔗 Read the Research Highlight:
https://doi.org/10.1038/d41573-025-00176-x